Academic CRO/Industrial Collaborations in Drug Discovery
Academic CRO/Industrial collaborations in drug discovery provides comprehension into the potential interaction of basing R&D in academia while leaving drug companies to turn hits into marketable products. These assist in increasing access to cutting-edge science, equipment, and resources for both universities and biopharmaceutical companies enabling the nation’s R&D enterprise to tackle the most complex and challenging diseases and conditions. In the face of an increasingly challenging R&D environment and global competition, we are likely to witness the continuing proliferation of AMC industry partnerships.
Related Conference of Academic CRO/Industrial Collaborations in Drug Discovery
August 29-30, 2018 |
International Conference and Exhibition on Drug Safety & Pharmacovigilance
Park Inn By Radisson Toronto Airport West, 175 Derry Road East, Mississauga, ON, L5T 2Z7, Canada
Academic CRO/Industrial Collaborations in Drug Discovery Conference Speakers
Recommended Sessions
- Academic CRO/Industrial Collaborations in Drug Discovery
- Advance Trends in Organic Chemistry & Inorganic Chemistry
- Anti-Cancer Drug Discovery
- CADD (Computer Aided Drug Designing)
- Clinical Trials
- Drug Discovery and Drug Development
- Drug Discovery of Rare Diseases
- Drug Discovery Using Nanotechnology
- Drug Formulation/ Pharmaceutical formulation
- Green Techniques for Medicinal Chemistry
- Hot Topics in Drug Targets
- In-silico Drug Design and in-silico screening
- Natural Products Drug Discovery
- Perspective in Drug Discovery
- Pharmaceutical Freeze Drying Technology
- Pharmaceutical Research & Development ( R&D)
- Pharmacology and Toxicology
- Process Chemistry and Drug Manufacturing
- Proteomics & Bioinformatics
- Recent trends in Nutraceuticals Research
- Structural biology in Drug Discovery
- Traditional Chinese Medicine Discovery
- Women’s Health Drug Discovery & Therapy
Related Journals
Are you interested in
- BCS & IVIVC Based Biowaivers - Asian Biosimilars 2018 (Japan)
- Bioequivalence Assessment - Asian Biosimilars 2018 (Japan)
- Biosimilar Companies and Market Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilar Market and Cost Analysis - Asian Biosimilars 2018 (Japan)
- Biosimilars Analytical Strategies - Asian Biosimilars 2018 (Japan)
- Biosimilars Research Pipeline - Asian Biosimilars 2018 (Japan)
- Brexit Effect on Biosimilars - Asian Biosimilars 2018 (Japan)
- Challenges in Developing Biosimilars - Asian Biosimilars 2018 (Japan)
- Clinical Studies on Biosimilars - Asian Biosimilars 2018 (Japan)
- Emerging Biosimilars in Therapeutics - Asian Biosimilars 2018 (Japan)
- Emerging Trends in Biosimilars - Asian Biosimilars 2018 (Japan)
- Entrepreneurs Investment Meet - Asian Biosimilars 2018 (Japan)
- Globalization of Biosimilars - Asian Biosimilars 2018 (Japan)
- Intellectual Property Rights - Asian Biosimilars 2018 (Japan)
- Latest Biosimilars in Asian Scenario - Asian Biosimilars 2018 (Japan)
- Legal Issues and BPCI Act - Asian Biosimilars 2018 (Japan)
- Pharmacovigilance of Biosimilars - Asian Biosimilars 2018 (Japan)
- Regulatory Approach for Biosimilars - Asian Biosimilars 2018 (Japan)